Advanced in Atherosclerosis

Dr. Lowell Satler

Cardiology
110 Irving Street Northwest Suite 4B-1
110 Irving St NW Ste 4B-1, 
Washington, DC 
Clinical Trials:Currently Recruiting for 1 Trial

Advanced in Atherosclerosis
110 Irving Street Northwest Suite 4B-1
110 Irving St NW Ste 4B-1, 
Washington, DC 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Lowell Satler is a Cardiologist in Washington, Washington, D.c.. Dr. Satler is rated as an Advanced provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Aortic Valve Stenosis, Aortic Regurgitation, Heart Attack, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement.

His clinical research consists of co-authoring 363 peer reviewed articles and participating in 13 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Atherosclerosis.

Specialties
Cardiology
Licenses
Internal Medicine in DC
Hospital Affiliations
Frederick Health Hospital
Medstar Washington Hospital Center
Luminis Health Anne Arundel Medical Center, Inc
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

110 Irving Street Northwest Suite 4B-1
110 Irving St NW Ste 4B-1, Washington, DC 20010
Call: 202-877-7464

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


13 Clinical Trials

Assessment of the Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild Functional Mitral Regurgitation
Assessment of the Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild Functional Mitral Regurgitation
Enrollment Status: Recruiting
Publish Date: November 10, 2025
Intervention Type: Device, Other
Study Phase: Not Applicable
ACURATE IDE: Transcatheter Replacement of Stenotic Aortic Valve Through Implantation of ACURATE in Subjects InDicatEd for TAVR
ACURATE IDE: Transcatheter Replacement of Stenotic Aortic Valve Through Implantation of ACURATE in Subjects InDicatEd for TAVR
Enrollment Status: Active_not_recruiting
Publish Date: December 10, 2025
Intervention Type: Device
Study Phase: Not Applicable
OSB Lead-AMPLATZER PFO Occluder New Enrollment PAS
OSB Lead-AMPLATZER PFO Occluder New Enrollment PAS
Enrollment Status: Active_not_recruiting
Publish Date: November 13, 2025
Intervention Type: Device
Study Phase: Not Applicable
The Safety and Effectiveness of the Edwards SAPIEN 3, SAPIEN 3 Ultra, and SAPIEN 3 Ultra RESILIA (SAPIEN 3/Ultra/RESILIA) Valve in Patients With Symptomatic Severe Calcific Mitral Valve Disease With Severe Mitral Annular Calcification Who Are Not Candidates for Standard Mitral Valve Surgery.
The Safety and Effectiveness of the Edwards SAPIEN 3, SAPIEN 3 Ultra, and SAPIEN 3 Ultra RESILIA (SAPIEN 3/Ultra/RESILIA) Valve in Patients With Symptomatic Severe Calcific Mitral Valve Disease With Severe Mitral Annular Calcification Who Are Not Candidates for Standard Mitral Valve Surgery.
Enrollment Status: Active_not_recruiting
Publish Date: March 14, 2025
Intervention Type: Device
Study Phase: Not Applicable
Annular ReduCtion for Transcatheter Treatment of Insufficient Mitral ValvE (ACTIVE): A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Assess Transcatheter Mitral Valve Repair With Edwards Cardioband System and GDMT vs GDMT Alone in Patients With FMR and Heart Failure
Annular ReduCtion for Transcatheter Treatment of Insufficient Mitral ValvE (ACTIVE): A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Assess Transcatheter Mitral Valve Repair With Edwards Cardioband System and GDMT vs GDMT Alone in Patients With FMR and Heart Failure
Enrollment Status: Terminated
Publish Date: November 30, 2023
Intervention Type: Drug, Device
Study Phase: Not Applicable
A Clinical Evaluation of the Safety and Effectiveness of the MitraClip® System for the Treatment of Functional Mitral Regurgitation in Symptomatic Heart Failure Subjects (COAPT Recruitment Closed). COAPT CAS (Recruitment Closed)
A Clinical Evaluation of the Safety and Effectiveness of the MitraClip® System for the Treatment of Functional Mitral Regurgitation in Symptomatic Heart Failure Subjects (COAPT Recruitment Closed). COAPT CAS (Recruitment Closed)
Enrollment Status: Unknown
Publish Date: November 27, 2023
Intervention Type: Device
Study Phase: Not Applicable
The Safety and Feasibility of the SAPIEN XTTM Transcatheter Heart Valve With NovaFlex and Ascendra Delivery Systems and SAPIEN 3 With Commander Delivery System in Patients With Symptomatic Severe Calcific Mitral Valve Disease With Severe Mitral Annular Calcification and Patients With Failing Mitral Surgical Rings or Bioprostheses Who Are Not Candidates for Mitral Valve Surgery.
The Safety and Feasibility of the SAPIEN XTTM Transcatheter Heart Valve With NovaFlex and Ascendra Delivery Systems and SAPIEN 3 With Commander Delivery System in Patients With Symptomatic Severe Calcific Mitral Valve Disease With Severe Mitral Annular Calcification and Patients With Failing Mitral Surgical Rings or Bioprostheses Who Are Not Candidates for Mitral Valve Surgery.
Enrollment Status: Completed
Publish Date: October 10, 2023
Intervention Type: Device
Study Phase: Not Applicable
Prospective Multicenter MANTA™ Vascular Closure Device Ultrasound Guided Closure Study
Prospective Multicenter MANTA™ Vascular Closure Device Ultrasound Guided Closure Study
Enrollment Status: Terminated
Publish Date: July 27, 2023
Intervention Type: Device
Study Phase: Not Applicable
PROTECTED TAVR: Stroke PROTECTion With SEntinel During Transcatheter
PROTECTED TAVR: Stroke PROTECTion With SEntinel During Transcatheter
Enrollment Status: Completed
Publish Date: February 02, 2023
Intervention Type: Device
Study Phase: Not Applicable
Strategies to Prevent Transcatheter Heart Valve Dysfunction in Low Risk Transcatheter Aortic Valve Replacement
Strategies to Prevent Transcatheter Heart Valve Dysfunction in Low Risk Transcatheter Aortic Valve Replacement
Enrollment Status: Unknown
Publish Date: January 04, 2022
Intervention Type: Other, Device
Study Phase: Not Applicable
Carotid With Bivalirudin Angioplasty
Carotid With Bivalirudin Angioplasty
Enrollment Status: Completed
Publish Date: October 28, 2020
Intervention Type: Device
Study Phase: Phase 2
Percutaneous Mitral Valve Replacement EvaLuation Utilizing IDE Early Feasibility Study (PRELUDE)
Percutaneous Mitral Valve Replacement EvaLuation Utilizing IDE Early Feasibility Study (PRELUDE)
Enrollment Status: Unknown
Publish Date: January 28, 2020
Intervention Type: Device
Study Phase: Not Applicable
Pivotal Clinical Study to EvaluAte the SaFety and Effectiveness of MANTA Vascular Closure Device
Pivotal Clinical Study to EvaluAte the SaFety and Effectiveness of MANTA Vascular Closure Device
Enrollment Status: Completed
Publish Date: September 25, 2019
Intervention Type: Device
Study Phase: Not Applicable
View 12 Less Clinical Trials

363 Total Publications

Transcatheter aortic valve implantation with the Trilogy valve for symptomatic native aortic regurgitation (ALIGN-AR): a pivotal, multicentre, single-arm, investigational device exemption study.
Transcatheter aortic valve implantation with the Trilogy valve for symptomatic native aortic regurgitation (ALIGN-AR): a pivotal, multicentre, single-arm, investigational device exemption study.
Journal: Lancet (London, England)
Published: September 30, 2025
View All 363 Publications
Similar Doctors
Michael J. Blaha
Elite in Atherosclerosis
Dr. Michael J. Blaha
Cardiology
Elite in Atherosclerosis
Dr. Michael J. Blaha
Cardiology

Johns Hopkins Health Care & Surgery Center - Green Spring Station, Lutherville

10755 Falls Road, Pavilion I STE 360, Pavilion I STE 360, 
Lutherville, MD 
 (40.5 miles away)
443-997-0270
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Dr. Michael J. Blaha MD MPH is Professor of Cardiology and Epidemiology and presently serves as the Director of Clinical Research for the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Director of the Cardiometabolic Clinic, and Program Director for the Preventive Cardiology Fellowship. His clinical interests include primary and secondary prevention of cardiovascular disease, with emphasis on early intervention in patients with advanced subclinical atherosclerosis detected with cardiac computed tomography. Dr. Blaha represents the 4th generation of physicians in his family. After earning a BS in pre-medical studies and classical civilization at the University of Notre Dame in 2001, Dr. Blaha went to Vanderbilt University where in 2006 he received his MD as well as an MPH. in clinical epidemiology and biostatistics. Dr. Blaha then completed his Internal Medicine residency in the Osler Medical Housestaff Training Program at Johns Hopkins in 2009 before completing a fellowship in Cardiology at Johns Hopkins in 2012. In 2018, Dr. Blaha received the Dr. Fred Brancati award at Johns Hopkins for excellence in mentoring. He has mentored over 30 trainees, many of which have gone on to hold prominent academic appointments. In 2021, Dr. Blaha was named to the Clarivate Highly Cited Researcher List, representing the top 1% of world’s researchers, and was first named to the Baltimore Magazine Best Doctors List. In 2022, he received the Arthur S. Agatston Cardiovascular Disease Prevention Award. Clinically, he practices as a preventive cardiologist specializing in cardiometabolic disease and in the interpretation of cardiac CT. His clinic specializes in patients with cardiometabolic disease and advanced subclinical atherosclerosis, and the focused use of an array of lifestyle and pharmacotherapies to mitigate that risk. Dr. Blaha is rated as an Elite provider by MediFind in the treatment of Atherosclerosis. His top areas of expertise are Atherosclerosis, Coronary Heart Disease, High Cholesterol, Metabolic Syndrome, and Percutaneous Coronary Intervention (PCI).

Erin D. Michos
Elite in Atherosclerosis
Dr. Erin D. Michos
Cardiology
Elite in Atherosclerosis
Dr. Erin D. Michos
Cardiology

Johns Hopkins Health Care & Surgery Center - Green Spring Station, Lutherville

10755 Falls Road, Pavilion I STE 360, Pavilion I STE 360, 
Lutherville, MD 
 (40.5 miles away)
443-997-0270
Languages Spoken:
English
See accepted insurances

Dr. Erin D. Michos is a Professor of Medicine within the Division of Cardiology at Johns Hopkins School of Medicine, with joint appointment in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health. She is the Director of Women's Cardiovascular Health and the Associate Director of Preventive Cardiology within the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease. Dr. Michos is an internationally known expert in Preventive Cardiology and Women’s Health, having authored >700 publications and 11 book chapters. Her research involves (1) Women’s Cardiovascular Health; (2) Lipids and Lipid management; (3) Cardio-Kidney-Metabolic and Obesity disease management (4) Coronary artery calcium, inflammation and biomarkers of cardiovascular risk. She is the co-Editor-in-Chief for the American Journal of Preventive Cardiology. She is Co-Director of the IMPACT Center (Improving Participation Among Diverse Populations in Cardiovascular Clinical Trials) at Johns Hopkins, funded by the American Heart Association (AHA). She is a co-investigator in several NIH-funded studies including the Multi-Ethnic Study of Atherosclerosis and Atherosclerosis Risk in Communities cohorts. She has served as the Training Director for four AHA Strategic Focused Research Networks. She has mentored over 60 individuals and the recipient of 2 mentoring awards. Additionally, she was the recipient of the Nanette Wegner Award for Women’s Health Medical Leadership by the Women Heart Organization and the Donna Vogel Women’s Health Champion Award by Johns Hopkins University. Dr. Michos completed medical school at Northwestern University, Internal Medicine residency and Cardiology fellowship at the Johns Hopkins Hospital, and a Masters of Health Science degree at the Johns Hopkins Bloomberg School of Public Health. Dr. Michos is rated as an Elite provider by MediFind in the treatment of Atherosclerosis. Her top areas of expertise are Atherosclerosis, Vitamin D Deficiency, Peripartum Cardiomyopathy, Percutaneous Coronary Intervention (PCI), and Thrombectomy.

Wendy S. Post
Elite in Atherosclerosis
Dr. Wendy S. Post
Cardiology
Elite in Atherosclerosis
Dr. Wendy S. Post
Cardiology

Johns Hopkins Health Care & Surgery Center - Green Spring Station, Lutherville

Lutherville, MD 
 (40.5 miles away)
443-997-0270
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Dr. Wendy Post is professor of medicine at the Johns Hopkins University School of Medicine and holds a joint appointment as professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health. She is the Lou and Nancy Grasmick Professor of Cardiology. Dr. Post is a cardiologist at the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease and the Echocardiography Laboratory and is associate faculty at the Welch Center for Prevention, Epidemiology, and Clinical Research at Johns Hopkins University. She is Director of Cardiovascular Research for the Division of Cardiology and Director of Research for the Hopkins Cardiovascular Fellowship Training Program. Dr. Post received her undergraduate degree in biology from Harvard University. She earned her medical degree from Columbia College of Surgeons and Physicians, Columbia University. After completing her internship and residency at Harvard Medical School’s Beth Israel Hospital, Dr. Post received her master’s degree in epidemiology from the Harvard School of Public Health. She was a research fellow at the Framingham Heart Study, in Framingham, Mass., and completed a fellowship in cardiology at The Johns Hopkins Hospital. Dr. Post joined the Johns Hopkins faculty in 1997. Dr. Post’s research interests include prediction and prevention of coronary heart disease and sudden cardiac death, noninvasive imaging of subclinical atherosclerosis, genetics of cardiovascular disease, sex and racial/ethnic differences in cardiovascular disease, and cardiovascular disease in HIV/AIDS and COVID-19. She is the chair of the steering committee, and the principal investigator for the Hopkins field center for the NIH-funded Multi-Ethnic Study of Atherosclerosis (MESA). Dr. Post also leads Multicenter AIDS Cohort Study (MACS) Cardiovascular Disease sub-studies. She has been the PI for three R01 grants from NHLBI investigating cardiovascular disease in HIV, and is dual PI on the cardiology NHLBI training grant, which has been continuously funded for over 45 years. Dr. Post is a manuscript reviewer for multiple publications and is currently associate editor of Circulation. She has over 350 peer-reviewed research publications. Dr. Post was elected as a member of the American Society for Clinical Investigation (ASCI) in 2015. She mentors multiple medical students, medical house staff, fellows and junior faculty. She was a member of the Hopkins Professorial Promotions Committee and a former Johns Hopkins University Provost Fellow. She was co-chair of the Johns Hopkins University Committee on the Biomedical Scientific Workforce. Dr. Post is rated as an Elite provider by MediFind in the treatment of Atherosclerosis. Her top areas of expertise are Atherosclerosis, Coronary Heart Disease, Carotid Artery Disease, Hormone Replacement Therapy (HRT), and Aortic Valve Replacement.

VIEW MORE ATHEROSCLEROSIS DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Satler's expertise for a condition
ConditionClose
  • Elite
  • Aortic Regurgitation
    Dr. Satler is
    Elite
    . Learn about Aortic Regurgitation.
    See more Aortic Regurgitation experts
  • Aortic Valve Replacement
    Dr. Satler is
    Elite
    . Learn about Aortic Valve Replacement.
    See more Aortic Valve Replacement experts
  • Aortic Valve Stenosis
    Dr. Satler is
    Elite
    . Learn about Aortic Valve Stenosis.
    See more Aortic Valve Stenosis experts
  • Heart Attack
    Dr. Satler is
    Elite
    . Learn about Heart Attack.
    See more Heart Attack experts
  • Mitral Valve Regurgitation
    Dr. Satler is
    Elite
    . Learn about Mitral Valve Regurgitation.
    See more Mitral Valve Regurgitation experts
  • Percutaneous Coronary Intervention (PCI)
    Dr. Satler is
    Elite
    . Learn about Percutaneous Coronary Intervention (PCI).
    See more Percutaneous Coronary Intervention (PCI) experts
View All 7 Elite Conditions
  • Distinguished
  • Acute Coronary Syndrome
    Dr. Satler is
    Distinguished
    . Learn about Acute Coronary Syndrome.
    See more Acute Coronary Syndrome experts
  • Angina
    Dr. Satler is
    Distinguished
    . Learn about Angina.
    See more Angina experts
  • Angioplasty
    Dr. Satler is
    Distinguished
    . Learn about Angioplasty.
    See more Angioplasty experts
  • Atrial Septal Defect (ASD)
    Dr. Satler is
    Distinguished
    . Learn about Atrial Septal Defect (ASD).
    See more Atrial Septal Defect (ASD) experts
  • Cardiogenic Shock
    Dr. Satler is
    Distinguished
    . Learn about Cardiogenic Shock.
    See more Cardiogenic Shock experts
  • Coronary Heart Disease
    Dr. Satler is
    Distinguished
    . Learn about Coronary Heart Disease.
    See more Coronary Heart Disease experts
View All 10 Distinguished Conditions
  • Advanced
  • Apoplexy
    Dr. Satler is
    Advanced
    . Learn about Apoplexy.
    See more Apoplexy experts
  • Arterial Embolism
    Dr. Satler is
    Advanced
    . Learn about Arterial Embolism.
    See more Arterial Embolism experts
  • Atherectomy
    Dr. Satler is
    Advanced
    . Learn about Atherectomy.
    See more Atherectomy experts
  • Atherosclerosis
    Dr. Satler is
    Advanced
    . Learn about Atherosclerosis.
    See more Atherosclerosis experts
  • Atrial Fibrillation
    Dr. Satler is
    Advanced
    . Learn about Atrial Fibrillation.
    See more Atrial Fibrillation experts
  • Bicuspid Aortic Valve
    Dr. Satler is
    Advanced
    . Learn about Bicuspid Aortic Valve.
    See more Bicuspid Aortic Valve experts
View All 20 Advanced Conditions
  • Experienced
  • Adenosine Deaminase 2 Deficiency
    Dr. Satler is
    Experienced
    . Learn about Adenosine Deaminase 2 Deficiency.
    See more Adenosine Deaminase 2 Deficiency experts
  • Arrhythmias
    Dr. Satler is
    Experienced
    . Learn about Arrhythmias.
    See more Arrhythmias experts
  • Arrhythmogenic Right Ventricular Cardiomyopathy
    Dr. Satler is
    Experienced
    . Learn about Arrhythmogenic Right Ventricular Cardiomyopathy.
    See more Arrhythmogenic Right Ventricular Cardiomyopathy experts
  • Atrial Myxoma
    Dr. Satler is
    Experienced
    . Learn about Atrial Myxoma.
    See more Atrial Myxoma experts
  • Atrial Tachycardia
    Dr. Satler is
    Experienced
    . Learn about Atrial Tachycardia.
    See more Atrial Tachycardia experts
  • Atrioventricular Nodal Reentrant Tachycardia (AVNRT)
    Dr. Satler is
    Experienced
    . Learn about Atrioventricular Nodal Reentrant Tachycardia (AVNRT).
    See more Atrioventricular Nodal Reentrant Tachycardia (AVNRT) experts
View All 60 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.